HVHugo E. Verdejo

Hugo E. Verdejo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hugo E. Verdejo has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea del Campo

    Laboratorio de Fisiología y Bioenergética Celular (LABFBE), Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile

    2 shared publications
  • Sergio Lavandero

    Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas & Facultad de Medicina, Universidad de Chile, Santiago, 8380494, Chile; Núcleo de Biología y Genética (NiBG), Instituto de Ciencias Biomedicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8330351, Chile; Cardiology Division, Harry S. Moss Heart Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9047, USA

    2 shared publications
  • Alejandro H. Corvalan

    Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Portugal 61, Santiago 8330023, Chile

    1 shared publication
  • Andrew Frederick Geoffery Quest

    Cellular Communication Laboratory, Center for Studies on Exercise, Metabolism and Cancer (CEMC), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile; Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, University of Chile, Santiago, Chile

    1 shared publication
  • Andrés Vega-Moraga

    Translational Biomedical Laboratory, Facultad de Ingeniería, Universidad Tecnológica Metropolitana, Santiago 7800002, Chile

    1 shared publication
  • Benjamín Díaz‐Ortiz

    Laboratory of Exercise Physiology Department of Kinesiology School of Health Sciences Faculty of Medicine Pontificia Universidad Católica de Chile Santiago Chile

    1 shared publication

Latest Publications

  • Open Access

    microRNA-15b modulates stress-induced premature senescence in chronic doxorubicin cardiomyopathy

    by Georthan Mancilla, Clara Quiroga, Pablo Castro, Ivonne Olmedo, Hugo Verdejo, Zully Pedrozo

    Introduction: Doxorubicin (DOX) is the most widely used anthracycline in hematologic and solid tumors, whose clinical utility is constrained by dose-dependent cumulative cardiotoxicity that can progress to chronic heart failure. Although previously attributed to overt cardiomyocyte loss, emerging evidence indicates that stress-induced premature senescence (SIPS) constitutes the dominant mechanism of chronic cardiotoxicity at clinically relevant concentrations. SIPS is defined by permanent cell cycle arrest, activation of the p53/p21 and p16/Rb tumor suppressor axes, mitochondrial dysfunction, and a senescence-associated secretory phenotype (SASP) that sustains a pro-inflammatory myocardial milieu. Nevertheless, the post-transcriptional mechanisms that govern this process remain incompletely understood. Methods: The post-transcriptional regulation of DOX-induced SIPS was evaluated in vitro using neonatal rat ventricular myocytes (NRVMs) exposed to sublethal DOX (0.1 μM) with or without prophylactic miR-15b restoration via a synthetic mimetic to assess the p53/p21, p16, SASP, lysosomal, and mitochondrial responses. In vivo , a chronic cardiotoxicity model was established in female C57BL/6 mice receiving a cumulative dose of 30 mg/kg DOX to analyze myocardial miR-15b suppression, SIPS markers, and SASP profiles across survival cohorts. Results: Sublethal DOX treatment (0.1 μM) suppressed miR-15b expression by approximately 50% in NRVMs, resulting in post-transcriptional derepression of its mitochondrial target, SIRT4. This miR-15b loss triggered a multiparametric SIPS phenotype encompassing accumulation of γH2AX foci, p53/p21 and p16 activation, SASP induction (IL-6, IL-1β, Mcp-1 and Mmp13), lysosomal dysfunction (increased SA-β-Gal staining) and mitochondrial dysfunction. Prophylactic restoration of miR-15b via a synthetic mimetic selectively attenuated the p53/p21 axis, genomic damage foci, lysosomal dysfunction, mitochondrial dysfunction and SASP (IL-6 and IL-1β), without rescuing the p16/Rb pathway. In the female C57BL/6 chronic cardiotoxicity model, the cohort spontaneously stratified into animals completing the protocol (ND; 67%) and a premature death subgroup (PD; 33%). The PD subgroup exhibited the most profound myocardial miR-15b suppression and greater accumulation of SIPS markers, including γH2AX, p16, and reduced Lamin B. Notably, the SASP displayed distinct qualitative profiles between PD and ND animals, suggesting that SASP composition, rather than magnitude alone, determines the cardiotoxic outcome. Conclusion: Collectively, these findings position miR-15b as a key post-transcriptional regulator of DOX-induced SIPS in the cardiomyocyte, whose sustained loss associates with cardiotoxicity severity in vivo .

  • Open Access

    Sex differences in the prefrontal cortex and muscle oxygenation during exercise until exhaustion in endurance‐trained individuals

    by Daniel Ramos‐López, Raúl Caulier‐Cisterna, Benjamín Díaz‐Ortiz, Cristóbal Baumann‐Biancani, Kamilo Hunger‐Abbott, Matías Herrera‐Matas, Andrés Vega‐Moraga, Vitor A. Lira, Maximiliano Espinosa‐Ramírez, Karol Ramírez‐Parada, et al.

    Biological sex influences exercise performance, largely owing to anatomical and physiological differences in brain areas involved in cognitive motor control and in respiratory and locomotor muscles related to workload. We used near‐infrared spectroscopy data to examine sex differences in haemodynamic responses and oxygenation patterns in the prefrontal cortex (PFC), m. intercostales and m. vastus lateralis during incremental exercise in 74 endurance‐trained individuals. Changes (Δ) in oxyhaemoglobin (O 2 ‐Hb), deoxyhaemoglobin (H‐Hb) and tissue saturation index (TSI) were analysed using a two‐way ANOVA with the factors ‘sex’ and ‘intensity’. Effect sizes (ES) were also reported by partial eta squared (η p 2 ). Interactions were observed for ΔO 2 ‐Hb at the PFC [ p < 0.001, η p 2 = 0.42 (large ES)] and m. intercostales [ p < 0.001, η p 2 = 0.38 (large ES)], but not at m. vastus lateralis ( p = 0.160). For ΔH‐Hb, interactions were observed at m. vastus lateralis [ p < 0.001, η p 2 = 0.35 (large ES)] and the PFC [ p = 0.048, η p 2 = 0.18 (large ES)]. The ΔTSI also showed an interaction at m. vastus lateralis [ p < 0.001, η p 2 = 0.44 (large ES)] and a trend in the m. intercostales ( p = 0.057). Male subjects demonstrated greater oxygen delivery to the brain and increased peripheral deoxygenation, whereas females exhibited greater oxygen extraction in respiratory muscles, despite smaller body surface area. Higher tissue oxygen extraction reflects the capacity to meet local metabolic demands during exercise, enabling the identification of distinct oxygenation patterns between sexes. These findings suggest that sex‐specific mechanisms contribute to different patterns of physiological response to exercise. We support the hypothesis that peripheral factors might be more limiting in males, whereas in females central limitations (such as potential reduced oxygen delivery to the PFC owing to possible cerebral vasoconstriction triggered by metabolic reflexes) might play a more prominent role.


  • Open Access

    mTOR inhibition triggers mitochondrial fragmentation in cardiomyocytes through proteosome-dependent prohibitin degradation and OPA-1 cleavage

    by Hugo E. Verdejo, Valentina Parra, Andrea del Campo, Cesar Vasquez-Trincado, Damian Gatica, Camila Lopez-Crisosto, Jovan Kuzmicic, Leslye Venegas-Zamora, Ursula Zuñiga-Cuevas, Mayarling F. Troncoso, et al.

    Introduction: Cardiac mitochondrial function is intricately regulated by various processes, ultimately impacting metabolic performance. Additionally, protein turnover is crucial for sustained metabolic homeostasis in cardiomyocytes. Objective: Here, we studied the role of mTOR in OPA-1 cleavage and its consequent effects on mitochondrial dynamics and energetics in cardiomyocytes. Results: Cultured rat cardiomyocytes treated with rapamycin for 6–24 h showed a significant reduction in phosphorylation of p70S6K, indicative of sustained inhibition of mTOR. Structural and functional analysis revealed increased mitochondrial fragmentation and impaired bioenergetics characterized by decreases in ROS production, oxygen consumption, and cellular ATP. Depletion of either the mitochondrial protease OMA1 or the mTOR regulator TSC2 by siRNA, coupled with an inducible, cardiomyocyte-specific knockout of mTOR in vivo, suggested that inhibition of mTOR promotes mitochondrial fragmentation through a mechanism involving OMA1 processing of OPA-1. Under homeostatic conditions, OMA1 activity is kept under check through an interaction with microdomains in the inner mitochondrial membrane that requires prohibitin proteins (PHB). Loss of these microdomains releases OMA1 to cleave its substrates. We found that rapamycin both increased ubiquitination of PHB1 and decreased its abundance, suggesting proteasomal degradation. Consistent with this, the proteasome inhibitor MG-132 maintained OPA-1 content in rapamycin-treated cardiomyocytes. Using pharmacological activation and inhibition of AMPK our data supports the hypothesis that this mTOR-PHB1-OMA-OPA-1 pathway impacts mitochondrial morphology under stress conditions, where it mediates dynamic changes in metabolic status. Conclusions: These data suggest that mTOR inhibition disrupts mitochondrial integrity in cardiomyocytes by promoting the degradation of prohibitins and OPA-1, leading to mitochondrial fragmentation and metabolic dysfunction, particularly under conditions of metabolic stress.


  • Open Access

    Multi-scale mitochondrial cristae remodeling links Opa1 downregulation to reduced OXPHOS capacity in aged hearts

    by Isidora Molina-Riquelme, Gonzalo Barrientos, Leonhard Breitsprecher, Wileidy Gómez, Francisco Díaz-Castro, Silke Morris, Andrea del Campo, Luis Garrido-Olivares, Hugo Verdejo, Olympia Ekaterini Psathaki, et al.

    Aging is closely associated with cardiovascular diseases, the leading cause of mortality worldwide. Mitochondrial dysfunction is a hallmark of cardiovascular aging because it generates most of the heart’s ATP at the cristae, specialized sub-compartments where OXPHOS takes place. In this study, we used multiple-scale electron microscopy approaches to evaluate age-related mitochondrial and cristae ultrastructural alterations in human and mouse hearts. We found that aged patients’ hearts displayed reduced cristae density as seen by TEM, even before any significant decline in the expression of cristae-shaping proteins. Similarly, a multi-scale approach that included SBF-SEM and TEM showed that in aged mice’s hearts cristae undergo ultrastructural remodeling processes, resulting in a decrease in cristae density and width. Electron tomography suggests an apparent decline in cristae connectivity, and an increase in fenestration size. These changes were linked to Opa1 downregulation, accompanied by reduced OXPHOS maximal respiration, but unrelated to alterations in the levels of OXPHOS core subunits and ATP synthase assembly. Altogether, this indicates that alterations in cristae structure alone are sufficient to impair oxidative metabolism, which highlights its potential as an early signal of cardiac aging, even before noticeable changes in mitochondrial morphology occur.


  • Top Cited Papers

    Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases

    by Mariana Cifuentes, Hugo E. Verdejo, Pablo F. Castro, Alejandro H. Corvalan, Catterina Ferreccio, Andrew F. G. Quest, Marcelo J. Kogan, Sergio Lavandero

    Inflammation is an important physiological response of the organism to restore homeostasis upon pathogenic or damaging stimuli. However, the persistence of the harmful trigger or a deficient resolution of the process can evolve into a state of low-grade, chronic inflammation. This condition is strongly associated with the development of several increasingly prevalent and serious chronic conditions, such as obesity, cancer, and cardiovascular diseases, elevating overall morbidity and mortality worldwide. The current pandemic of chronic diseases underscores the need to address chronic inflammation, its pathogenic mechanisms, and potential preventive measures to limit its current widespread impact. The present review discusses the current knowledge and research gaps regarding the association between low-grade chronic inflammation and chronic diseases, focusing on obesity, cardiovascular diseases, digestive diseases, and cancer. We examine the state of the art in selected aspects of the topic and propose future directions and approaches for the field.


  • Open Access

    ADAPTACIÓN CULTURAL Y ANÁLISIS PSICOMÉTRICO DE UNA ESCALA DE COMPORTAMIENTOS DE AUTOCUIDADO EN PERSONAS CON INSUFICIENCIA CARDÍACA

    by Marcela Gonzalez Madrid, Victor Pedrero Castillo, Carmen Luz Guardamagna Molinos, Charlotte Saavedra Maino, Lilian Ferrer Lagunas, Hugo Verdejo Pinochet

    INTRODUCCIÓN: La Insuficiencia Cardiaca se ha descrito como un síndrome de proporciones epidémicas, con una prevalencia de un 1-3% de la población adulta mundial menor de 60 años. Las conductas de autocuidado constituyen una estrategia clave en la elaboración de intervenciones exitosas que disminuyan la re-hospitalización, mortalidad y mejoren la calidad de vida. OBJETIVO: Adaptar y validar la Escala Revisada de Comportamientos de Autocuidado en Falla Cardiaca (Revised Heart Failure Self Care Behavior Scale) en personas con insuficiencia cardíaca, que se encuentran en seguimiento ambulatorio, en dos Hospitales Públicos chilenos. METODOLOGÍA: Estudio transversal de adaptación y análisis psicométrico del instrumento de medición Escala de Valoración de Comportamientos de Autocuidado en personas con Insuficiencia Cardíaca diseñada por Nancy Artinian. Emplazamiento: Unidades ambulatorias de seguimiento en Hospitales Públicos chilenos. Participantes: Usuarios con Insuficiencia Cardíaca que asistieron a dos Policlínicos de seguimiento de Insuficiencia Cardiaca de dos Centros de Salud de nivel secundario de dos comunas de Santiago en Chile. Método: Se realizó juicio de expertos para la adaptación cultural del instrumento, se aplicó el análisis factorial exploratorio con rotación oblicua. RESULTADOS: Escala Chilena de Valoración Comportamientos de Automanejo en Insuficiencia Cardiaca presentó una adecuada adaptación cultural, pruebas sicométricas que garantizan su validez de constructo y fiabilidad adecuada, con Alfa de Cronbach del Instrumento de 0,84 IC [0,80-0,88]. CONCLUSIONES: Se proporciona un instrumento que permite conocer conductas de autocuidado de los pacientes con IC, esto le permite ser utilizado por los profesionales que atienden a personas que padecen de IC en Chile.

  • Open Access

    Polución por material particulado fino (PM 2,5) incrementa las hospitalizaciones por insuficiencia cardiaca

    by Pablo Castro, Jeanette Vera, Luis Cifuentes, Gregory Wellenius, Hugo Verdejo, Luis Sepúlveda, José Luis Vukasovic, Silvana Llevaneras

    Antecedentes: Estudios recientes han reportado una asociación entre la contaminación ambiental por material particulado (PM) y el riesgo de hospitalizaciones de pacientes con insuficiencia cardiaca (IC). La región metropolitana de nuestro país constituye un área geográfica en la cual la contaminación es especialmente relevante, asociándose a incrementos periódicos en la morbimortalidad por causa respiratoria. Sin embargo el efecto de la polución por PM en la morbilidad de pacientes con IC no ha sido evaluado en forma sistemática. Objetivo: Evaluar la asociación entre el PM fino y las hospitalizaciones por IC descompensada en hospitales pertenecientes al registro ICARO del área metropolitana. Métodos: Estudio prospectivo. Entre enero 2002 a diciembre de 2008 se recolectaron las fichas médicas de 529 pacientes residentes de Santiago hospitalizados por IC descompensada. Las variables meteorológicas y de contaminación fueron obtenidas de la red MACAM. Para estudiar la asociación entre las hospitalizaciones y los niveles de contaminación (PM10 y PM2,5), se aplicó un diseño de Casos cruzados estratificado por tiempo (Time-stratified Case-crossover), controlando por temperatura y punto de rocío. El impacto de los niveles de contaminación en el número de hospitalizaciones se evaluó asumiendo una latencia en el efecto de la polución de 0 a 10 días. Resultados: La edad media de la población en estudio fue de 73.8 años. La etiología más frecuente fue isquémica (27%) e hipertensiva (27%). Un 73.2% de los pacientes eran hipertensos y 32.6% tenían antecedentes de diabetes mellitus. Se observó un aumento en la admisión por IC descompensada en pacientes de ambos sexos, menores de 74 años, con desde un 22.7% (p=0.03) por cada incremento en 10 ug/m3 de PM2.5 calculado con media móvil, cuatro días después de la exposición hasta un 44.8% (p=0.006) a 10 días de la exposición. Los pacientes con antecedentes de diabetes mellitus fueron más susceptibles, observándose en ellos un aumento de un 18.8% (p=0.035) de las hospitalizaciones por IC por cada incremento de 10 ug/m3 de PM2.5, ocho días después de la exposición. Los pacientes hipertensos de ambos sexos, menores de 74 años, también mostraron ser suceptibles, con un 22.8% (2.1-43.5)% con día 5 de la exposición. Mostrando que este efecto puede ser modificado según sexo y edad. Conclusión: Nuestros resultados sugieren que pacientes con IC con antecedente de diabetes mellitus e hipertensos, son especialmente susceptibles a la exposición a material particulado, fino y presentan un alto riesgo de hospitalización en relación con incrementos del PM2,5, siendo un factor modificador el sexo y la edad del paciente Los mecanismos involucrados en este fenómeno no han sido estudiados.